Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Exploring the Tardive Dyskinesia Treatment Landscape and INGREZZA’s Potential Impact

Ticker(s): NBIX

Who's the expert?

Institution: Banner Sun Health Research Institute

Board-certified neurologist specializing in movement disorders, with extensive experience in diagnosing and treating tardive dyskinesia and related conditions.
Currently manages 30 patients for tardive dyskinesia.
Research interests center on advancing treatments for movement disorders, particularly tardive dyskinesia, through clinical trials and investigations into novel therapies like INGREZZA (valbenazine).

Interview Goal

This call will examine the current treatment landscape for tardive dyskinesia, highlighting existing therapies and their limitations. We will also discuss the potential of INGREZZA (valbenazine) as a transformative option, focusing on its efficacy, safety profile, and role in addressing unmet needs.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.